Highbridge Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Highbridge Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-762,301	Closed	-$229K	–	365
2023 Q4	$229K	Sell	762,301 -237,699	-24%	-$73.4K	0.01%	131
2023 Q3	$300K	Hold	1,000,000	–	–	0.01%	161
2023 Q2	$160K	Buy	1,000,000 +800,000	+400%	+$131K	0.01%	192
2023 Q1	$28K	Buy	+200,000	New	+$20.3K	﹤0.01%	378

Highbridge Capital Management's DMAQR Position: Q1 2024 in Review

Highbridge Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 762,301 shares — an estimated $229K sold.

Highbridge Capital Management first reported a position in DMAQR in Q1 2023 and held it in 4 quarters. The position peaked at $300K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Highbridge Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Highbridge Capital Management sold 762,301 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $229K.
Highbridge Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q1 2023 and held it in 4 quarters.
Highbridge Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $300K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Highbridge Capital Management's 13F filing for Q1 2024, filed 10 May 2024.